Literature DB >> 20631572

Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.

Georgios Paslakis, Maria Gilles, Michael Deuschle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20631572     DOI： 10.1097/JCP.0b013e3181e5c0e4

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  A case of hypomania during nicotine cessation treatment with bupropion.

Authors:  Karine Giasson-Gariépy; Didier Jutras-Aswad
Journal:  Addict Sci Clin Pract       Date:  2013-12-21

Review 3.  A review of significant pharmacokinetic drug interactions with antidepressants and their management.

Authors:  Charity Hoffelt; Tonya Gross
Journal:  Ment Health Clin       Date:  2016-03-08

Review 4.  Consensus statements on the clinical understanding and use of bupropion in Hong Kong.

Authors:  Wing-King Lee; Kwok-Leung Au Yeung; Ho-Bun Lam; Chi-Keung Wong; Ting-Chi Wong; Chi-Kin Fu; Shiu-Kow Sham; Ming-Kai Au; Tat-Chung Lam; Daniel Ki-Yan Mak
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.